Free Trial
→ A new rule goes live in July — and the banks are quietly cashing in (From American Alternative) (Ad) Free ESPR Stock Alerts

Esperion Therapeutics (ESPR) SEC Filings & 10K Form

Esperion Therapeutics logo
$1.15 +0.15 (+15.00%)
Closing price 07/2/2025 04:00 PM Eastern
Extended Trading
$1.16 +0.01 (+0.43%)
As of 08:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Esperion Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
07/01/2025
7:14 AM		Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2025
5:44 PM		Esperion Therapeutics (Issuer)
Halladay Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
5:44 PM		Esperion Therapeutics (Issuer)
Koenig Sheldon L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
5:45 PM		Esperion Therapeutics (Issuer)
Looker Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2025
2:34 PM		Esperion Therapeutics (Subject)
Halladay Benjamin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2025
2:16 PM		Esperion Therapeutics (Subject)
Looker Benjamin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/08/2025
8:01 AM		Esperion Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2025
6:25 AM		Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2025
11:15 PM		Esperion Therapeutics (Filer)
Form EFFECT
04/17/2025
3:20 PM		Esperion Therapeutics (Filer)
Form DEFA14A
04/17/2025
3:24 PM		Esperion Therapeutics (Filer)
Form ARS
04/17/2025
2:08 PM		Esperion Therapeutics (Subject)
Warren Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/17/2025
2:14 PM		Esperion Therapeutics (Subject)
Halladay Benjamin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/07/2025
1:15 PM		Esperion Therapeutics (Subject)
WASATCH ADVISORS LP (Filed by)
Form SCHEDULE 13G/A
04/04/2025
3:15 PM		Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2025
2:20 PM		Esperion Therapeutics (Subject)
Halladay Benjamin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/18/2025
2:23 PM		Esperion Therapeutics (Subject)
Warren Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/18/2025
2:11 PM		Esperion Therapeutics (Subject)
Koenig Sheldon L. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/17/2025
4:15 PM		Esperion Therapeutics (Issuer)
Looker Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
4:16 PM		Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
4:16 PM		Esperion Therapeutics (Issuer)
Halladay Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
4:17 PM		Esperion Therapeutics (Issuer)
Koenig Sheldon L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
10:12 AM		BB BIOTECH AG (Filed by)
Esperion Therapeutics (Subject)
Form SCHEDULE 13G/A
03/07/2025
8:04 AM		Esperion Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/04/2025
6:26 AM		Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2025
2:34 PM		Esperion Therapeutics (Subject)
Warren Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/19/2025
2:26 PM		Esperion Therapeutics (Subject)
Halladay Benjamin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
1:37 PM		BB BIOTECH AG (Filed by)
Esperion Therapeutics (Subject)
Form SCHEDULE 13G/A
01/21/2025
3:37 PM		Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2025
3:38 PM		Esperion Therapeutics (Issuer)
Halladay Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
2:30 PM		Esperion Therapeutics (Subject)
Warren Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2025
2:17 PM		Esperion Therapeutics (Subject)
Halladay Benjamin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2025
7:40 AM		Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
3:12 PM		Esperion Therapeutics (Issuer)
Koenig Sheldon L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
3:13 PM		Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
3:14 PM		Esperion Therapeutics (Issuer)
Halladay Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
6:10 AM		Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2024
2:46 PM		Esperion Therapeutics (Subject)
Warren Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/17/2024
2:21 PM		Esperion Therapeutics (Subject)
Halladay Benjamin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/17/2024
2:22 PM		Esperion Therapeutics (Subject)
Koenig Sheldon L. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/13/2024
5:43 AM		Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Top Picks for Trump’s Pro-Crypto America (Ad)

Mark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…

Claim your pass to the Crypto Community Summit here (free for a limited time)
11/14/2024
7:42 AM		Esperion Therapeutics (Subject)
Two Seas Capital LP (Filed by)
Form SC 13G/A
11/12/2024
1:23 PM		Esperion Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/07/2024
3:22 PM		Esperion Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
6:22 AM		Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
12:33 PM		Esperion Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
11:09 AM		Esperion Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/22/2024
5:06 PM		BlackRock, Inc. (Filed by)
Esperion Therapeutics (Subject)
Form SC 13G
10/18/2024
3:08 PM		Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2024
3:34 PM		Esperion Therapeutics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
Form SC 13G/A
10/17/2024
2:25 PM		Esperion Therapeutics (Subject)
Warren Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
3:11 PM		Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:12 PM		Esperion Therapeutics (Issuer)
Koenig Sheldon L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
2:20 PM		Esperion Therapeutics (Subject)
Koenig Sheldon L. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/17/2024
2:28 PM		Esperion Therapeutics (Subject)
Warren Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/12/2024
3:33 PM		Esperion Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/12/2024
3:08 PM		Esperion Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
6:21 AM		Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2024
7:29 AM		Esperion Therapeutics (Issuer)
Foody Joanne M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
7:30 AM		Esperion Therapeutics (Issuer)
Warren Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
2:22 PM		Esperion Therapeutics (Subject)
Warren Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/17/2024
2:11 PM		Esperion Therapeutics (Subject)
Foody Joanne M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:ESPR) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners
Trump’s New Order Could Boost Social Security Benefits by 400%
If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...
InvestorPlace | Sponsored
The $15 Gold Fund That Pays Up to $1,152/Month
Gold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...
Investors Alley | Sponsored
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...
Paradigm Press | Sponsored
Buffett’s $325 Billion Cash Problem — Solved by Gold?
A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...
Golden Portfolio | Sponsored
A grave, grave error.
President Donald Trump made headlines last month with a staggering claim. He stated that since taking offic...
Porter & Company | Sponsored
Post-Halving = Profit Season (Here’s How to Win It)
It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...
Crypto Swap Profits | Sponsored
The $7 company helping Nvidia build the world’s first trillion-dollar robot …
Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...
Weiss Ratings | Sponsored
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsored